Zurueck zur Suche

Reporte zur Charge U8096AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
1Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
TX 1 NC 1 NY 1 GA 1 OH 1 CA 1

VAERS 2682547

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge u8096aa

kritisch
Staat
TX
Alter
6,0
Geschlecht
F
Eingang
15.09.2023
Impfdatum
07.09.2023
Beginn
13.09.2023
Tage bis Beginn
6,0
Dosis
N/A
Route/Site
IM / LL
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood gases Blood grouping C-reactive protein Cardio-respiratory arrest Full blood count Procalcitonin Red blood cell sedimentation rate Red blood cell transfusion Resuscitation Transfusion

Symptomtext

09/13/23 2300 arrived to emergency department 09/14/2023 0815 code started, chest compressions, epinephrine x 10 throughout code, plasmalyte, calcium chloride, plasma and packed RBC administered 09/14/2023 0930 code ended

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
-
Labordaten
9/13/23 & 9/14/23 CBC, CRP, ESR, procalcitonin, ABG, blood type
Aktuelle Erkrankungen
9/5/23 Pharyngitis
Vorgeschichte
Vascular malformation of lower limb
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2721747

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8096AA

schwer
Staat
NC
Alter
45,0
Geschlecht
M
Eingang
07.12.2023
Impfdatum
18.10.2023
Beginn
03.11.2023
Tage bis Beginn
16,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Blood thyroid stimulating hormone normal Computerised tomogram head normal Full blood count normal Guillain-Barre syndrome Immunoglobulin therapy Intensive care Lumbar puncture abnormal Magnetic resonance imaging head normal Magnetic resonance imaging spinal normal Metabolic function test normal Muscular weakness Neurological symptom Paraesthesia Prothrombin level normal Prothrombin time normal Vitamin B12 normal

Symptomtext

AIDP - Guillain Barre Syndrome. Paresthesias began 11/3/23 (Stocking and glove distribution; Ascending motor weakness in lower extremity began 11/12/23; ICU hospitalization: 11/12/23 - 11/16/23. Treated with IVIG infusions. Neuro symptoms began to improve during hospitalization.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
5,0
Labordaten
11/12/23: MRI Brain, MRI C & T Spine - Neg 11/12/23: CBC, CMP, TSH, B12, PT/PTT - Within Normal Limits 11/12/23: LP demonstrated albuminocystologic dissociation seen in GBS. 11/14/23: CT Head - Neg
Aktuelle Erkrankungen
None
Vorgeschichte
GERD
Andere Medikamente
Trazadone 50mg PRN Omeprazole 20mg QD
Allergien
Penicillin - Urticaria
Vorherige Impfungen
-

VAERS 2711740

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge U8096AA

mild
Staat
NY
Alter
29,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
24.10.2023
Beginn
01.10.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Headache

Symptomtext

received an expired dose of FLUZONE; headache; Initial information received on 26-Oct-2023 regarding an unsolicited valid non-serious case received from a Patient. This case involves a 29 years old female patient who experienced headache and received an expired dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included meningococcal vaccine a/c/y/w conj (dip tox) (Menactra) for Prophylactic vaccination. On 24-Oct-2023, the patient received a dose of suspect influenza quadrival a-b multidose vaccine preserved [fluzone] suspension for injection (lot- U8096AA and expiration date- 30-Jun-2023) via intramuscular route in the left arm (dose, strength: not provided) for Immunisation (expired product administered) (latency- same day) On an unknown date in Oct- 2023 the patient developed headache (unknown latency) following the administration of Action taken- not applicable. It was not reported if the patient received a corrective treatment for the events (headache). At time of reporting, the outcome was Recovered / Resolved in 2023 for the event headache and was Unknown for the event received an expired dose of fluzone. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MENACTRA
Allergien
-
Vorherige Impfungen
-

VAERS 2698438

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8096AA

mild
Staat
GA
Alter
3,0
Geschlecht
M
Eingang
19.10.2023
Impfdatum
27.09.2023
Beginn
28.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain Injection site warmth Pain

Symptomtext

redness and pain at the injection site, painful to walk- mom administered Benadryl; on exam there was a 22 cm area of warmth, tenderness on right anterior thigh, extending inferiorly to above the knee; Cephalexin and Prednisolone prescriptions given

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
moderate persistent asthma
Andere Medikamente
Flovent 44 mg inhaler
Allergien
none known
Vorherige Impfungen
influenza vaccine given on 9/29/2022 also made his leg swell; he was 2 years of age; Fluzone Quad Lot #UJ878AB

VAERS 2721720

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8096AA

gering
Staat
OH
Alter
3,0
Geschlecht
F
Eingang
07.12.2023
Impfdatum
18.11.2023
Beginn
07.12.2023
Tage bis Beginn
19,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Pt received Fluzone 0.5 mL on 10/4/23 by another provider. I gave Fluzone on 11/18/23. I verified name, DOB, and expected vaccine with parent, however I did not check to see if the patient recently received the vaccine. I called patient's parent today to notify them of the error but there was no answer.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2691341

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge u8096AA

gering
Staat
CA
Alter
33,0
Geschlecht
F
Eingang
05.10.2023
Impfdatum
04.10.2023
Beginn
04.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Exposure during pregnancy

Symptomtext

Vocational Nurse students performing vaccination under the supervision of staff. The student did not ask the patient about pregnancy and was given flu vaccine from multidose vial

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
person is pregnant
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2682013

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8096AA

gering
Staat
-
Alter
21,0
Geschlecht
F
Eingang
14.09.2023
Impfdatum
13.09.2023
Beginn
13.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

Received Pfizer Bivalent dose on 09/13/2023 - No adverse advent experienced.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-